Mental distress and ADHD symptoms among individuals in Opioid Maintenance Treatment

Abstract

This thesis investigates self-reported symptoms of mental distress and Attention Deficit Hyperactivity Disorder (ADHD) among individuals in Opioid Maintenance Treatment (OMT). Data was collected as part of the larger NorComt study through face-to-face interviews at treatment start and approximately one year later. Also included in the thesis is a small clinical trial from Oslo University Hospital that explored the viability of central stimulant medication for OMT patients with ADHD. The results demonstrate a high prevalence of mental distress and ADHD symptoms. For the group as a whole, mental distress was equally high at treatment start and after one year in treatment. Patients with high ADHD symptom scores reported more mental distress at treatment start and these symptoms had increased after one year in treatment. Our clinical trial showed some promise regarding use of central stimulant medication of ADHD in OMT, though challenges were present. In conclusion, we recommend that clinicians should focus on mental health and systematic screening to appropriately identify, diagnose and treat multimorbidities simultaneously.